It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Active responses to stressors involve motor planning, execution, and feedback. Here we identify an insular cortex to BNST (insula→BNST) circuit recruited during restraint stress-induced active struggling that modulates affective behavior. We demonstrate that activity in this circuit tightly follows struggling behavioral events and that the size of the fluorescent sensor transient reports the duration of the struggle event, an effect that fades with repeated exposure to the homotypic stressor. Struggle events are associated with enhanced glutamatergic- and decreased GABAergic signaling in the insular cortex, indicating the involvement of a larger circuit. We delineate the afferent network for this pathway, identifying substantial input from motor- and premotor cortex, somatosensory cortex, and the amygdala. To begin to dissect these incoming signals, we examine the motor cortex input, and show that the cells projecting from motor regions to insular cortex are engaged shortly before struggle event onset. This study thus demonstrates a role for the insula→BNST pathway in monitoring struggling activity and regulating affective behavior.
Active responses to stressors involve motor planning, execution, and feedback. The authors identify a neuronal projection from the insular cortex to the bed nucleus of the stria terminalis that is activated during motor struggling in response to restraint stress as a potential active coping response.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Vanderbilt University School of Medicine, Vanderbilt Center for Addiction Research, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Vanderbilt Brain Institute, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Vanderbilt J.F. Kennedy Center for Research on Human Development, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)
2 Vanderbilt University School of Medicine, Vanderbilt Center for Addiction Research, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Vanderbilt Brain Institute, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Vanderbilt J.F. Kennedy Center for Research on Human Development, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Department of Molecular Physiology & Biophysics, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)
3 Vanderbilt University School of Medicine, Vanderbilt Center for Addiction Research, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Vanderbilt Brain Institute, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Vanderbilt J.F. Kennedy Center for Research on Human Development, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Department of Molecular Physiology & Biophysics, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Department of Psychiatry and Behavioral Sciences, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)
4 Vanderbilt University School of Medicine, Vanderbilt Center for Addiction Research, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217); Vanderbilt University School of Medicine, Department of Molecular Physiology & Biophysics, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)